Business Context and Reporting Period
This Form 10-Q is a combined quarterly report for Corteva, Inc. and its wholly-owned subsidiary, EIDP, Inc., for the period ended June 30, 2026. Corteva operates in two primary segments: Seed and Crop Protection. The filing highlights a strategic intent announced in October 2025 to separate these two businesses into independent publicly traded companies. EIDP, Inc. continues to file as a separate reporting entity but its financial results are consolidated within Corteva, with EIDP's preferred stock classified as noncontrolling interest at the Corteva level.
Key Financial Metrics (Six Months Ended June 30, 2026)
| Metric | 2026 (6 Months) | 2025 (6 Months) | Change |
|---|---|---|---|
| Net Sales | $11,284 million | $10,873 million | +4% |
| Net Income (Attributable to Corteva) | $1,881 million | $1,966 million | -4% |
| Diluted EPS (Continuing Ops) | $2.88 | $2.98 | -3% |
| Operating EBITDA (Non-GAAP) | $3,699 million | $3,353 million | +10% |
| Cash from Operating Activities | $(3,357) million | $(1,162) million | Worsened |
| Total Debt | $4,875 million | $3,629 million | +34% |
| Cash & Equivalents | $2,365 million | $2,065 million | +15% |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 4% year-over-year, driven by a 2% favorable currency impact, 1% volume growth, and 1% price increase. The Seed segment saw a 4% sales increase, while Crop Protection grew 3%.
- Profitability Pressure: Despite higher Operating EBITDA, GAAP Net Income declined due to significant one-time charges. Restructuring and asset-related charges totaled $141 million (vs. $101 million prior year), and separation costs were $131 million (vs. $0 prior year).
- Cash Flow Deterioration: Operating cash flow turned significantly negative ($3.36 billion outflow) compared to the prior year. This was primarily driven by a $1.5 billion discretionary pension contribution, a $610 million settlement payment to Bayer, and higher working capital needs.
- Debt Increase: Total debt rose to $4.875 billion, largely due to increased short-term borrowings used to fund the Bayer settlement, working capital, and capital spending.
Guidance, Outlook, and Risks
- Proposed Separation: Management is actively preparing for the separation of Seed and Crop Protection businesses. This includes a 2026 Restructuring Program approved in March 2026, targeting $115–$125 million in annualized savings by 2027 through workforce reductions.
- Restructuring Outlook: The "Crop Protection Operations Strategy Restructuring Program" continues, with an intended cessation of production at the Asturias, Spain site. Total expected charges for this program range from $750 million to $815 million.
- Legal and Environmental Contingencies:
- FTC Investigation: Corteva reached settlement agreements with the FTC, the State of Arkansas, and multi-district litigation plaintiffs regarding antitrust allegations. Accruals have been established for estimated resolutions.
- PFAS Litigation: Significant ongoing exposure related to legacy EIDP businesses. A NJ Statewide Settlement was reached in August 2025 (subject to court approval) involving $875 million in aggregate payments over 25 years. Corteva's share is estimated at a net present value of approximately $500 million.
- Bayer Dispute: Resolved in January 2026 with a $610 million payment, terminating royalty obligations for Enlist E3 soybeans.
- Capital Allocation: The company returned approximately $740 million to shareholders in the first half of 2026 via dividends and share repurchases ($500 million in buybacks).
Investor Verification Checklist
- Separation Timeline: Verify the regulatory approval status and expected closing date for the proposed spin-off of Seed and Crop Protection businesses.
- Restructuring Execution: Monitor the progress of the 2026 Restructuring Actions and the Crop Protection Operations Strategy to ensure cost savings targets are met without disrupting operations.
- Legal Settlements: Confirm the final court approval of the NJ Statewide Settlement and the FTC/MDL settlements to assess the final cash outflow impact.
- Liquidity Management: Review the sustainability of the current debt levels ($4.9B) given the negative operating cash flow, ensuring sufficient access to credit facilities ($5.4B available) to fund seasonal working capital and pension obligations.
- Argentina Exposure: Assess the impact of the Argentine Peso devaluation and government restrictions on the company's net monetary assets and cash repatriation.